Sanofi Dives Deep Into Communities As China Elevates GPs’ Role
This article was originally published in PharmAsia News
Executive Summary
After bagging initial success in China's county hospital market, Sanofi is now targeting another potentially huge sector to drive growth: urban health service centers. While a policy tailwind to emphasize GPs’ role will help, segmented health insurance coverage, poor care quality, and lack of education will make the company's ambitious goal challenging.
You may also be interested in...
WHO’s Chan Outlines ‘Chinese Dream’ For Health Care Reforms
Relying on general practitioners instead of hospitals and increasing compensation to physicians can solve many health care reform issues in China, says the world's top public health official, who also discusses vaccine scandal in China and Zika infection risks during Rio Olympics.
Bounce Or More Bumps? New China Market Data Offer Bit Of Both
Two new sets of data on growth in China’s turbulent pharma sector paint a mixed and complex picture, indicating both challenges and opportunities ahead for multinational and domestic firms in the country.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.